TransMedics Group, Inc. — Director's Dealing 2024

Aug 23, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-08-21

Reporting Person: Hassanein Waleed H (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-21	Common Stock	M	20000	$16.00	Acquired	81643	Direct
2024-08-21	Common Stock	S	20000	$171.03	Disposed	61643	Direct
2024-08-22	Common Stock	M	25000	$16.14	Acquired	86643	Direct
2024-08-22	Common Stock	S	25000	$175.00	Disposed	61643	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-21	Stock Option (Right to Buy)	$16.00	M	20000	Disposed	2029-05-01	Common Stock (20000)	Direct
2024-08-22	Stock Option (Right to Buy)	$16.14	M	25000	Disposed	2030-02-27	Common Stock (25000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	469359	Indirect

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $171.00 to $171.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: The option is fully vested.

F3: The option is fully vested.